This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Aplidin and cytarabine effect on diffuse large B cell lymphoma cell line |
| Accession | GDS2295 |
| Summary | Analysis of diffuse large B cell lymphoma SKI-DLCL cells treated with Aplidin, cytarabine (AraC), or both anticancer drugs. The effect of the drugs on animals with SKI-DLCL cell-derived tumors also examined. Results provide insight into the action of Aplidin alone and in combination with AraC. |
| Organism | Homo sapiens |
| Platform | GPL571 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Cell_type | SKI-DLCL (diffuse large B cell lymphoma) cells |
| Drug_id | CID 9812534 |
| Drug_name | Aplidin |
| Organism | Human |
| Principal Component Analysis | |
| Hierarchical clustering |
| Gene lists | Enrichr | L1000CDS2 | PAEA | Crowdsourcing | |
| Up |
|
||||
| Down |
|
||||
| Combined |
|
|
|
|
